Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()
Aktuelle News
News Funktionen
Weitere Funktionen
22 Juli 2024
08:12
Corporate
EN
Biophytis
Corporate
EN
Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
11 Juli 2024
08:13
Corporate
EN
Biophytis
Corporate
EN
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
1 Juli 2024
07:00
Corporate
EN
Biophytis
Corporate
EN
Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
20 Juni 2024
07:00
Corporate
EN
Biophytis
Corporate
EN
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
01:10
Corporate
EN
Biophytis
Corporate
EN
Biophytis extends its contract with Atlas to secure financing for its business activities
12 Juni 2024
10:11
Corporate
EN
Biophytis
Corporate
EN
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens